Image Solutions, Inc. (ISI) Celebrates 15 Years of Significant Growth with Expansion and Industry Recognition

WHIPPANY, N.J., Aug. 16 /PRNewswire/ -- Image Solutions, Inc. (ISI), a leader in providing software and services to streamline the drug development and regulatory approval process, celebrates 15 years of record performance, global expansion, and recognition from multiple industry organizations. At a time when the Life Sciences regulatory landscape is in flux -- the FDA’s fast- approaching, end-of-year deadline for submissions in the electronic Common Technical Document (eCTD) format, for example -- it is no surprise that prestigious organizations such as Deloitte & Touche USA LLP, Ernst & Young and the American Business Awards are recognizing ISI’s innovative approaches and industry leadership.

Since the company’s founding in 1992, ISI’s pioneering regulatory solutions have driven average revenue growth rates of 30 percent; last year alone, the company reported a 60 percent increase in revenue over the same period in 2005. As of year-end 2006, the company increased its core client base by more than 50 percent to a total of 120 clients, including the top 50 Pharmaceutical and Biotechnology organizations worldwide.

In recognition of this growth, ISI was named to Deloitte’s prestigious Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area. It was the seventh year that ISI was included in Deloitte’s ranking, which is based on the percentage revenue growth over five years from 2002- 2006.

In addition to Deloitte’s acknowledgement, Ernst & Young named ISI president and CEO, Jinsoo Kim, as a 2007 finalist for their Entrepreneur of the Year program. Awards are given to entrepreneurs who have demonstrated excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities.

Earlier this year, ISI was named as a finalist for the 2007 American Business Awards in the category, “Most Innovative Company.” Kim was also recognized by the 2007 American Business Awards in the category, “Best Executive -- Computer or Hardware Services.” It was the third consecutive year he was named a finalist in the category. The American Business Awards, or Stevie(TM) awards, recognize the efforts and achievements of individual performers in business.

“We are extremely proud of these acknowledgments from such prominent organizations and look to continue this trend by taking the industry into the next phase of drug development and regulatory approval,” said Kim. “If Life Sciences organizations are able to navigate the ever-changing and increasingly global regulatory environment, the horizon holds a great deal of promise.”

ISI leadership is on the forefront of globalization in the Life Sciences industry and the company’s rising profits have enabled them to capitalize. The company is expanding to pursue new and emerging markets, domestically and abroad. In addition to its satellite offices in San Francisco and Frankfurt, ISI opened three additional offices in 2007: a European office in the United Kingdom and offices in the biotechnology-heavy regions of Boston and San Diego. In Asia Pacific, ISI has a broad presence with a development center in South Korea, a testing and support group in India through a partnership there, and a formal sales and marketing partnership through an alliance with CAC Corporation for the Japanese market.

To strengthen the company’s business process outsourcing capabilities, earlier this year ISI opened an office in China where the primary operational focus is Case Report Form (CRF) processing. CRFs are the most paper-intensive document process in the life science industry with more than 5 million CRF pages generated each week. With the addition of this office ISI now links multiple offices located in different time zones, leveraging Web-based technology to provide almost 400 man-hours of production time within a single 24-hour day.

About Image Solutions

Founded in 1992, Image Solutions, Inc (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. ISI was among the first professional services firm to deliver electronic submissions to the industry and since has delivered nearly 1,000 electronic submissions and 400 eCTD submissions. ISI serves the top 50 pharmaceutical and biotech organizations as well as the top companies in other regulated industries.

ISI is a privately held company with headquarters in Whippany, New Jersey and operations throughout the U.S., Europe and Asia. ISI also remains committed to giving back to society and sharing its success with others by donating 10 percent of annual net profits to over 20 recognized charitable organizations. For more information, visit the company website at www.imagesolutions.com

Press Contacts: Lisa Meyer Kurt Rossler Director, Global Marketing M Booth & Associates 973-560-0808 x. 217 212 481-7000 lisa.meyer@imagesolutions.comkurtr@mbooth.com

Image Solutions, Inc.

CONTACT: Media, Lisa Meyer, Director, Global Marketing of Image Solutions,Inc, +1-973-560-0808, ext. 217, lisa.meyer@imagesolutions.com, or KurtRossler of M Booth & Associates, +1-212-481-7000, kurtr@mbooth.com, forImage Solutions, Inc.

MORE ON THIS TOPIC